Marker Therapeutics Inc (NASDAQ: MRKR). Extremely significant negative changes in investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and negative upside/downside volume developed.
Small negative changes in Marker Therapeutics Inc (NASDAQ: MRKR) fundamentals have recently occurred: the stock’s power rating fell below 50.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, MRKR is expected to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Marker Therapeutics has a poor Power Rating of 25 and a very low Appreciation Score of 6, triggering the Lowest Value Trend Rating.
Recent Price Action
Marker Therapeutics Inc (NASDAQ: MRKR) stock enjoyed a large increase of 3.0% on 4/15/24. The stock closed at $4.44. Moreover, unusually high trading volume at 162% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months and has declined -4.9% during the last week.
Be the first to comment